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Abstract 
Objectives: There are plausible biological mechanisms for how increased 
physical activity (PA) may prevent pancreatic cancer, although findings from 
epidemiological studies are inconsistent. We investigated whether the risk is 
dependent on the age at which PA is measured, and if independent of body 
mass index (BMI). 
 
Methods: 23 639 participants, aged 40-74 years, were recruited into the 
EPIC-Norfolk cohort study between 1993 and 1997 and completed validated 
questionnaires on PA. The cohort was monitored for pancreatic cancer 
development and hazard ratios (HRs) were estimated, adjusted for covariates. 
 
Results: Within 17 years, 88 participants developed pancreatic cancer (55% 
female). There was no association between PA and risk in the cohort (HR 
trend=1.06, 95% CI=0.86-1.29). However, in participants younger than 60 
years, higher PA was associated with decreased risk (highest vs. lowest 
category HR=0.27, 95% CI=0.07-0.99). Higher PA was not inversely 
associated when older than 60 years (HR trend=1.23, 95% CI=0.96-1.57). 
Including BMI in all models, produced similar estimates.  
 
Conclusions: The reasons why PA in younger, but not older people, may 
prevent pancreatic cancer needs to be investigated. PA may operate through 
mechanisms independent of BMI. If this association is causal, one in six cases 
might be prevented by encouraging more PA.  
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Introduction 
Pancreatic cancer causes over a quarter of a million deaths each year 
worldwide,1 and has the worst survival rate of any malignancy.2,3 Only 3% of 
patients live for more than five years after diagnosis, with little improvement 
over recent decades.2,3 The incidence varies between countries,1,4 suggesting 
that lifestyle factors may play an important part in its etiology. Positive risk 
factors include: cigarette smoking,5 type 2 diabetes mellitus,6,7 and excess 
body weight,8,9 although the precise etiology is unknown. 
 
There are plausible biological mechanisms for how a decreased physical 
activity (PA) may promote pancreatic carcinogenesis. Increased insulin 
resistance and the resulting hyperinsulinaemia, are associated with several 
risk factors for cancer including: decreased PA,10 type 2 diabetes,11 and 
excess body weight.12 Hyperinsulinaemia, stimulates mitogenesis of beta cells 
in the pancreatic islets of Langerhans,13,14,15 with the excess insulin promoting 
increased expression of several cellular signaling pathways in pancreatic 
cells, including transforming growth factor beta (TGF-β).16 This enhanced 
transmission of signals from within cell membranes to the nucleus, may 
promote carcinogenesis.16 An increased PA is associated with improved 
insulin sensitivity,17 which lowers insulin secretion, thereby potentially 
inhibiting the carcinogenic processes. 
 
The mechanisms for how PA may protect against cancer, need to be 
supported by epidemiological data demonstrating that people with high levels 
of PA have a reduced risk of developing pancreatic cancer. The association 
between total PA and the development of pancreatic cancer has been 
reported in a meta-analysis of five prospective studies (RR=0.62, 95% 
CI=0.35-1.09, P=0.09) with similar results after adjustment for BMI (RR=0.81, 
95% CI=0.55-1.20).18 However, only one of these studies, from Finland, 
reported a statistically significant inverse association (HR=0.42, 95% CI=0.22-
0.83).19 None stratified their results according to age at recruitment when PA 
was measured, with all studies including participants older than 60 
years.20,21,22,23 The age at which PA is measured may be crucial in etiological 
studies, as younger participants are more likely to be both employed and 
healthier, hence pursue more PA. Greater PA at younger ages may reduce 
the risk of pancreatic cancer developing later. Furthermore, the range of PA 
may be less in older people and hence harder to detect associations in 
epidemiological studies. This lack of age-dependent measurement of PA may 
explain the null findings in many previous studies, which included older 
participants. Furthermore, clarifying whether PA has a potential protective 
effect independent of BMI is important. Those pursuing more PA may have a 
lower BMI and it could be the latter, which is truly associated with a reduced 
risk of pancreatic cancer. To date, not all cohort studies have adjusted for 
BMI, so whether PA has an independent effect, is currently uncertain. 
 
The aim of this epidemiological investigation was to conduct a prospective 
cohort study to determine if there is an inverse association between 
increasing levels of total PA and pancreatic cancer. For the first time, to the 
best of our knowledge, the age at which PA is measured will be studied to see 
if there is a differential effect. Furthermore, we would investigate such 
associations adjusting for BMI, to provide information on the potential 
mechanism. Demonstrating inverse associations would support measuring PA 
in etiological studies of pancreatic cancer according to age, and offer an 
approach to preventing this highly lethal cancer. 
 
Methods 
A total of 23 639 men and women aged between 40-74 years old were 
recruited into the European Prospective Investigation of Cancer (EPIC-
Norfolk) Study between the years 1993 to 1997.24 Potential participants were 
identified from 35 general practices in the county of Norfolk, United Kingdom. 
Participants completed a self-administered questionnaire recording 
information on their total PA in a typical week over the past year: PA was 
assessed: firstly at work (classed into categories of either; sedentary, 
standing, physical work or heavy manual), secondly at home (housework, 
gardening, do-it-yourself work) and thirdly at recreation (walking, cycling, 
jogging etc.). The PA questionnaire recorded details of the intensity and 
duration of these activities, and also the number of flights of stairs climbed 
each day. From these questions, a global total PA index was derived, divided 
into four categories, namely: inactive, moderately inactive, moderately active, 
and active (Table 1). Within each category, the summation of occupational, 
home and recreational PA levels were similar. This PA index had been 
validated against physiological markers of exercise, namely cardiorespiratory 
fitness (as measured by sub-maximal oxygen consumption whilst cycling) and 
four-day energy expenditure (as determined by four day heart rate 
monitoring).25 At recruitment, participants also completed questionnaires on 
their demographics, medical history and their diet from seven-day food 
diaries. In the food diaries, participants recorded their entire food intake for a 
week including: food type, brands, recipes and portion sizes. All attended a 
health check which measured their height and weight measurements in light 
clothing, to calculate their BMI (kg/m2).  The Norwich District Health Authority 
Ethics Committee approved the study and all volunteers gave signed consent 
for their medical notes to be reviewed. 
 
After recruitment, the cohort was followed up to 2010, to identify those 
participants who developed incident pancreatic cancer. Cancer cases were 
identified by matching the EPIC-Norfolk database with the Norfolk Health 
Authority records of hospital admissions as well as the Eastern Region 
Cancer Registry. A medical gastroenterologist reviewed the medical notes of 
all potential cases to verify the diagnoses and to document the confirmatory 
investigations. Cases were excluded where there was: diagnostic uncertainty 
after review of notes, in those diagnosed with pancreatic cancer prior to 
recruitment or if the diagnosis was made less than 12 months after 
enrollment. The latter helped ensure that data on PA was recorded 
prospectively before symptoms developed.   
 
In the analysis, Cox regression estimated the hazard ratios (HR), plus 95% 
confidence intervals (95% CIs), for developing pancreatic cancer for each of 
the four categories of PA (Intercooled STATA, SE version 11.0). The lowest 
level of physical activity (inactive) was the reference value and in the first 
analysis, age at recruitment and gender were included in the model. In a 
second analysis, additional covariates which influence the etiology of 
pancreatic cancer namely: cigarette smoking (never, former, current smoker), 
and type 2 diabetes (yes, no) were included.11,18,26 These analyses were 
performed in a sub-cohort of 4 058, which consisted of a random sample of 
3970 non-cases plus the 88 identified cases. This approach was used so that 
nutrient information from participants with fully coded seven-day food diaries 
could be included in several analyses of PA. Currently all the nutrient 
information from the whole cohort is unavailable. Each of these analyses were 
performed firstly in all ages at recruitment, secondly participants younger than 
60 years and thirdly those older than 60 years. The age of 60 years was 
chosen as it is an estimated age after which participants may start retiring 
from their occupation and are more likely to develop medical illnesses, both of 
which may result in less PA. The HRs were adjusted for information from the 
food diaries, namely total energy intake, which is associated with PA, and total 
dietary antioxidant intake, for which we have previously reported inverse 
associations with the risk of pancreatic cancer.27 Finally, further analyses 
were performed to assess if the effects of PA were independent of BMI 
(categories of kg/m2, <25, 25-<30, 30-<35 and >35). The population 
attributable fraction was calculated, namely the proportion of cases that could 
be prevented, assuming a causal association, if participants in the lowest 
three categories of PA increased their PA to that in the active one.  
 
 
 
 
 
Results 
In the cohort of 23 639 participants, a random sample of 4058 were identified 
for whom we had information on PA and coded food diaries, including 88 
(2.17%) of whom developed pancreatic cancer (55% female, mean age at 
recruitment 64 years, SD=7.8 years). Pancreatic cancer was diagnosed after 
a mean follow-up time since recruitment of 8.6 years (SD=3.8 years). Most 
patients had metastatic spread at diagnosis (81%, American Joint Committee 
on Cancer, stage 428) and only 7% had cancer localized to the pancreas and 
less than 2 centimeters in dimension (stages 0, 1A or 1B). The treatments 
used were: surgery (8%), chemotherapy (35%) and palliative measures 
(57%). There was histological confirmation in 31 cases (35%), and in the 
remainder, the diagnosis was confirmed from firstly, at least two radiological 
modalities and secondly symptoms suggestive of pancreatic cancer. The 
clinical characteristics of patients with and without histology were similar 
namely: cancer staging and median survival of four months in both groups.  
 
In the descriptive analyses, participants who developed pancreatic cancer 
were more likely than controls to be older at recruitment. However, there were 
no significant differences in BMI, cigarette smoking status or the prevalence of 
diabetes (table 2). In all ages of recruitment, there were no significant 
differences in proportions of cases and non-cases in each of the four 
categories of PA. Data on BMI category was collected in 99.8% of non-cases 
and 100% of the cases and data on smoking was collected in 99.2% of non-
cases and 100% of the cases. 
 
 
In the multivariate analyses of all ages at recruitment, there were no 
associations between PA and the risk of pancreatic cancer for any individual 
categories, or for trends across categories (HR trend=1.06, 95% CI=0.86-
1.29, P=0.60, table 3). At recruitment 52.8% of participants were younger than 
60 years. In this group, more did have increased PA compared to participants 
older than 60 years (active 23.8% vs. 12.1%, P=0.07 and moderately active 
27.3% vs. 17.5%, P=0.07). For patients recruited younger than 60 years 
(n=29 cases) there were inverse associations with the three higher quartiles of 
PA, although only the active category reached statistical significance 
(HR=0.27, 95% CI=0.07-0.99, table 4), with a non-significant trend across 
categories (HR trend=0.75, 95% CI=0.53-1.06, P=0.11, table 4). In 
participants recruited older than 60 years (n=59 cases), no association was 
found with PA and pancreatic cancer risk (active vs. inactive HR=1.98, 95% 
CI=0.94-4.16, P=0.07, HR trend=1.23, 95% CI=0.96-1.57, P<0.10, table 5). 
Potential reasons for this might be that; firstly that there may be residual 
confounders associated with PA in this age group, which have an adverse 
effect on risk. Secondly if the carcinogenetic process occurs over many years, 
PA may only influence this process in younger people. All the HRs were 
similar when adjusted for both total energy intake and total dietary antioxidant 
intake. If the association with PA is causal, and based on the HRs reported, 
then 47% of pancreatic cancers could be prevented in those younger than 60 
years, if those in the three least active categories increased their PA to that of 
the active level. When including BMI in the models, the effect sizes for all PA 
categories and trends were similar for all ages of recruitment (HR trend=1.03, 
95% CI=0.84-1.27, P=0.77) and in those aged younger than 60 years (highest 
vs. lowest category HR=0.25, 95% CI=0.07-0.93, HR trend=0.73, 95% 
CI=0.51-1.04, P=0.08, table 4). Similarly, in participants recruited older than 
60 years, the magnitude of associations were comparable (HR trend=1.21, 
95% CI=0.94-1.55, P=0.13, table 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The main finding of this study was that the associations between PA and the 
risk of pancreatic cancer were dependent on the age at which PA was 
measured. There was a large, although imprecise, inverse association in 
those undertaking higher levels of PA when younger than 60 years, with 
participants who were active (a standing job or with >1.0 hour daily 
recreational activity) 73% less likely to develop pancreatic cancer. Evidence 
for a causal association with PA is suggested by: the large effect size, 
suggestion of a dose response and the temporal measurement of PA. The 
epidemiological findings support the experimental work on possible biological 
mechanisms for how PA may inhibit pancreatic carcinogenesis.16 These 
include, PA reducing hyperinsulinaemia, with lowering of the mitogenic effects 
of excess insulin which may lead to a decreased expression of several cellular 
signaling pathways involved in carcinogenesis. In participants, older than 60 
years at recruitment, higher PA was not associated with a decreased risk. The 
reasons for this are unknown, but may reflect residual confounders in older 
people which are associated with both PA, which negate any potential 
beneficial effects of PA. This research will continue to investigate other 
exposures, including diet, and assess if these are linked with PA and may 
explain this finding. Additionally, if the carcinogenetic process evolves over 
many years, increased PA may only exert an influence on this process in 
younger people. Investigating whether the effect of PA is independent of BMI 
is important, to help elucidate the potential protective mechanisms of the 
former. A raised BMI, which is associated with hyperinsulinaemia, is also 
decreased by increased PA levels. However, our results showed the 
association remained even when BMI was included in the analyses, 
suggesting the effect of PA indicates mechanisms independent of simply 
reducing BMI.  
 
The influence of PA on risk, many years before the actual diagnosis of cancer, 
possibly suggests a long time period during which pancreatic carcinogenesis 
evolves. Ductal adenocarcinoma, the commonest pancreatic cancer, has 
been postulated to arise from histological abnormalities in the ducts, called 
pancreatic intraepithelial neoplasias (PanINs).29 The histological changes in 
PanINs; include metaplasia and cellular atypia which can progress to 
malignant cancer over time.29 Perhaps increasing levels of PA in younger 
people influence mechanisms, which inhibit the progression of such pre-
cancerous lesions, thereby decreasing the risk of pancreatic cancer. 
 
This investigation had both methodological strengths and weaknesses. The 
former, are its prospective design and the use of a questionnaire measuring 
PA, which had been validated against physiological parameters. The 
measurements of PA from the questionnaire are highly correlated with 
objective measures of energy expenditure (P = 0.003) and cardiorespiratory 
fitness (P=0.001).25 A cohort study is superior to a retrospective case-control 
design in that both recall and selection biases are minimized. In etiological 
studies it is important that PA before symptoms is recorded, as once 
symptoms develop, PA will be reduced. In a case-control study, patients may 
have difficulty in recalling their pre-symptomatic PA levels and report their 
current PA level. This recall bias is reduced in prospective work, where 
participants are recruited when they are well and report their current levels of 
PA. Follow-up bias will have been low due to use of comprehensive cancer 
registries to identify cases and the stable geographical nature of the 
population in Norfolk. Twenty years after cohort recruitment commenced, 
94.6% of EPIC-Norfolk participants were still resident in the county. To 
minimize potential confounding, the covariates of age, sex, cigarette smoking 
status, type 2 diabetes and BMI were all included in our analyses. 
Furthermore, adjusting for energy intake and antioxidant consumption did not 
influence the results. The findings are generalizable in that the population and 
clinical characteristics, namely incidence, cancer staging, treatments and 
survival were similar to that expected.30 Moreover, PA in Norfolk was 
comparable to that in other counties in the United Kingdom, with national data 
reporting 60% of the population meeting recommendations for at least 
moderate activity (59.3% moderately active or active in our non-cases).31 The 
main potential weakness of our work was that only one PA measurement was 
used, which could introduce measurement error, if PA changes over time. 
Regular, repeated recordings of PA would reduce this but we did not have 
access to this information. However, such measurement error would result in 
a spurious under-estimate, not over-estimate, of any effects of PA. 
Furthermore, only 35% of cases had histological confirmation of pancreatic 
cancer, potentially introducing misclassification bias. In the early years after 
recruitment, namely in the 1990s, more recently developed radiological 
techniques for obtaining tissue, namely endoscopic ultrasound with fine 
needle aspiration of tissue, were unavailable. However, this bias is unlikely as 
there were clinical similarities between cases with or without histology, 
including cancer staging and survival. Also to reduce error, for all patients 
without histology, the medical notes were reviewed by a medical 
gastroenterologist to confirm a likely diagnosis of pancreatic cancer. Finally, 
the number of cases in the active group younger than 60 years was low at 3 
cases, which resulted in imprecision of the effect size. Despite this, in several 
models the estimate was still statistically significant, with more cases in the 
baseline reference category and several hundred controls in the comparator 
groups. However, the cohort should continue to be monitored to accrue more 
cases to ensure the effect size is maintained.  
 
To help confirm that increased levels of total PA, in younger people, may 
contribute to preventing cancer, supportive data from many epidemiological 
studies are required, ideally prospective ones. To the best of our knowledge, 
there are currently five other such studies, which have investigated total PA. 
In the largest, analyzing data from the whole EPIC cohort of 438 405 males 
and females from 10 European countries,20 of which EPIC-Norfolk is a sub-
cohort of 6%, there were 324 cases of pancreatic cancer. No significant 
associations were reported across all ages of recruitment (recruitment age 
range, 19-84 years),20 although the effects of PA according to particular ages 
were not assessed. The Hawaii-Los Angeles Multiethnic cohort study which 
studied 167 430 participants, including 472 cases of pancreatic cancer, 
reported no association with PA (recruitment age range, 45-75 years).21 The 
Finnish Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study of 
29 048 males with 172 cases of pancreatic cancer, was the only study which 
documented a significant inverse association with PA (HR=0.42, 95% 
CI=0.22-0.83).19 A US study in the Breast Cancer Detection Demonstration 
Project (BCDDP) of 33 530 participants, of which 70 developed pancreatic 
cancer, did not report any associations (recruitment age range, 30-91 
years).23 The Japan Public Health Centre (JPHC) study of 99 670 participants 
with 224 cases of pancreatic cancer, again found no associations (recruitment 
age range, 45-75 years).22 The null findings in most of these studies may 
have been due to age-dependent PA at recruitment not being measured. This 
is important as PA is likely to significantly change once an individual ceases 
work i.e. retires, as occupational activity is a major contributor to PA levels. 
 
In summary, this prospective study reported large, although imprecise, inverse 
associations with higher levels of PA in those younger than 60 years and the 
development of pancreatic cancer. This association was independent of BMI. 
The lack of associations reported from other etiological studies may be due to 
differences in the age at which PA was recorded and future work should 
perhaps specifically measure this. If a causal association is confirmed by 
consistent findings from other epidemiological studies, then population based 
PA recommendations may help to prevent this highly aggressive cancer. 
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